Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by NETOUScaronEK, M.
Right arrow Articles by DVORcaronÁK, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NETOUScaronEK, M.
Right arrow Articles by DVORcaronÁK, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1957, Vol. 12, No. 4, pp. 391-397.
© 1957 American Society of Hematology, Inc.


Chronic Myelosis Following the Use of Thorotrast

M. NETOUScaronEK 1, J. BOREScaron 1, and K. DVORcaronÁK 1

1 First Clinic of Internal Medicine, Charles University, Prague, and Department of Radiology and Internal Medicine, Tábor Hospital, Czechoslovakia.

Following hepatolienography which was carried out in a woman aged 52 in 1931, for a tumor of the right kidney which was removed at operation, chronic myelosis developed in 1954. This was remarkable for the absence of splenomegaly, a relatively mild course and a paradoxic reaction to x-ray irradiation of the spleen, when instead of the expected decrease there was a doubling in the number of leukocytes. A causal relationship of myeloid leukemia to the thorotrast administered 23 years previously cannot be excluded.

Submitted on June 8, 1956
Accepted on September 20, 1956


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1957 by American Society of Hematology         Online ISSN: 1528-0020